The portfolio of our preclinical Neuropharmacology group covers various validated transgenic and non-transgenic in vivo and in vitro models for neurodegeneration such as AD, PD, for orphan diseases including HD and ALS , for lipid storage disease and dyslipidemia, and for diseases like psychosis, anxiety, schizophrenia, or autism. read more
QPS Austria Mission, Vision & Values
QPS Austria Mission Statement
The portfolio of our preclinical Neuropharmacology group covers various validated transgenic and non-transgenic in vivo and in vitro models for neurodegeneration such as AD, PD, for orphan diseases including HD and ALS , for lipid storage disease and dyslipidemia, and for diseases like psychosis, anxiety, schizophrenia, or autism.
QPS Austria Vision Statement
We will assist with designing a developmental plan for your small molecules or biologics and together with our DMPK and Toxicology colleagues we help you navigate toward clinical research.
QPS Austria Values
- Quality
- Service
- Relaiblity
Mission, Vision & Values at Similar Size Companieson Comparably
×